• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Portugal: 2022/2023 Monkeypox

Translation Google

Highlights History

Weekly information on Human Infection by Monkeypox Virus – Nº 005

i035702.jpg
​


Information on the number of cases in Portugal until August 3, 2022

On May 3, the presence of the Monkeypox virus (VMPX) was detected in Portugal, with laboratory confirmation of five cases of human infection by VMPX. Since then, through August 3, 2022, 710 confirmed cases have been identified.

As of August 3, 2022, 616 cases were reported on SINAVEmed (Figure 1). Of the 616 cases, most belong to the age group between 30 and 39 years (262; 43%). Most cases are male (534; 99.6%), with 4 cases (0.6%) reported female.

Actions at national level

On July 16, vaccination of the first contacts close to cases began, according to the eligibility criteria of Norm 006/2022 of 07/12/2022. Up to 1 August, 73 contacts had been vaccinated, out of the 104 considered eligible (70.2%). Eligible contacts in the different regions continue to be identified and targeted for vaccination.

The DGS is attentive to the epidemiological situation, both nationally and internationally, monitoring and adapting, when necessary, the implementation of public health measures, namely with regard to vaccination.

Open document (PDF - 250 Kb)


https://www.dgs.pt/em-destaque/info...nfecao-humana-por-virus-monkeypox--n-005.aspx
 
Translation Google

Highlights History

Weekly information on Human Infection by Monkeypox Virus – Nº 006
i035715.jpg
​



Information on the number of cases in Portugal until August 10, 2022

On May 3, the presence of the Monkeypox virus (VMPX) was detected in Portugal, with laboratory confirmation of five cases of human infection by VMPX. From then until August 10, 2022, 770 confirmed cases were identified.

As of August 10, 2022, 678 cases were reported on SINAVEmed (Figure 1). Of the 678 cases, most belong to the age group between 30 and 39 years (290; 43%). Most cases are male (673; 99.3%), with 5 cases (0.7%) reported in females.

Actions at national level

On July 16, vaccination of the first contacts close to cases began, according to the eligibility criteria of Norm 006/2022 of 07/12/2022. Up to 1 August, 73 contacts had been vaccinated, out of the 104 considered eligible (70.2%). Eligible contacts in the different regions continue to be identified and targeted for vaccination. The DGS is attentive to the epidemiological situation, both nationally and internationally, monitoring and adapting, when necessary, the implementation of public health measures, namely with regard to vaccination.


https://www.dgs.pt/em-destaque/infor...ox--n-006.aspx
 
Translation Google

Highlights History

Weekly information on Human Infection by Monkeypox Virus – Nº 007
i035722.jpg
​



Information on the number of cases in Portugal until August 17, 2022.

On May 3, the presence of the Monkeypox virus (VMPX) was detected in Portugal, with laboratory confirmation of five cases of human infection by VMPX. From then until August 17, 2022, 810 confirmed cases were identified.

As of August 17, 2022, 729 cases were reported on SINAVEmed (Figure 1). Of the 729 cases, most belong to the age group between 30 and 39 years (308; 42%). Most cases are male (723; 99.2%), with 6 cases (0.8%) reported in females.

Actions at national level

On July 16, vaccination of the first contacts close to cases began, according to the eligibility criteria of Norm 006/2022 of 07/12/2022. By August 13, 215 contacts had been vaccinated. Eligible contacts in the different regions continue to be identified and targeted for vaccination.

The DGS is attentive to the epidemiological situation, both nationally and internationally, monitoring and adapting, when necessary, the implementation of public health measures, namely with regard to vaccination.

Open document (PDF - 192 Kb)


https://www.dgs.pt/em-destaque/infor...ox--n-007.aspx
 
Source: https://www.theportugalnews.com/news/2022-08-26/portugal-monkeypox-cases-up-to-846/69786

Portugal Monkeypox cases up to 846
The number of confirmed cases of infection with the Monkeypox virus in Portugal rose to 846, 36 more than the total reported last week, the Directorate-General for Health (DGS) reported.
By TPN/Lusa, in News, Portugal · 26 Aug 2022

DGS data is released weekly and updated until the previous Wednesday. The first five cases were confirmed in Portugal on May 3.

According to information released by the DGS, of the 749 cases, most (337) are people between 30 and 39 years old and men (742).

The DGS states that eligible contacts in the different regions continue to be identified and oriented towards vaccination, noting that, in conjunction with the national medicine regulator and the vaccination technical commission, "it is analysing and evaluating the conditions of operation/availability and equity in the management of the limited vaccine stock for the preventive vaccination approach"...
 
Translation Google

Highlights History

Weekly information on Human Infection by Monkeypox Virus – Nº 009
i035795.jpg
​



Information on the number of cases in Portugal until August 31, 2022

On May 3, the presence of the Monkeypox virus (VMPX) was detected in Portugal, with laboratory confirmation of five cases of human infection by VMPX. From then until August 31, 2022, 871 confirmed cases were identified.

As of August 31, 2022, 796 cases were reported on SINAVEmed (Figure 1). Of the 796 cases, most belong to the age group between 30 and 39 years (353, 44%). Most cases are male (788; 99.0%), with 8 cases (1.0%) reported in females.

Actions at national level

On July 16, vaccination of the first contacts close to cases began, according to the eligibility criteria of Norm 006/2022 of 07/12/2022. Until August 28, 338 contacts had been vaccinated. Eligible contacts in the different regions continue to be identified and targeted for vaccination.

The DGS is attentive to the epidemiological situation, both nationally and internationally, monitoring and adapting, when necessary, the implementation of public health measures, namely with regard to vaccination. The DGS, in conjunction with INFARMED IP and the Technical Commission on Vaccination, is analyzing and evaluating the conditions of operationalization/availability and equity in the management of the limited stock of vaccines for the approach of preventive vaccination. This analysis and evaluation covers technical and logistical aspects, in addition to the authorization of exceptional use and training of health professionals for the use of reduced doses of vaccination for adults.

Open document (PDF - 496 Kb)


https://www.dgs.pt/em-destaque/infor...ox--n-009.aspx
 
Translation Google

Weekly information on Human Infection by Monkeypox Virus – Nº 010

i035821.jpg
​


Information on the number of cases in Portugal until September 7, 2022

On May 3, the presence of the Monkeypox virus (VMPX) was detected in Portugal, with laboratory confirmation of five cases of human infection by VMPX. Since then, through September 7, 2022, 898 confirmed cases have been identified.

As of September 7, 2022, 831 cases were reported on SINAVEmed (Figure 1). Of the 831 cases, most belong to the age group between 30 and 39 years (367; 44%). Most cases are male (823; 99%), with 8 cases (1%) reported in females.

Actions at national level

On July 16, vaccination of the first contacts close to cases began, according to the eligibility criteria of Norm 006/2022 of 07/12/2022. By September 4, 400 contacts had been vaccinated. Eligible contacts in the different regions continue to be identified and targeted for vaccination.

The DGS, in conjunction with INFARMED IP, the Technical Commission on Vaccination, the public health departments of the ARS and their respective regional vaccination teams, is analyzing and evaluating the conditions of operationalization/availability and equity in the management of the limited reserve of vaccines for the preventive vaccination approach. This analysis and evaluation covers technical and logistical aspects, in addition to the authorization of exceptional use and training of health professionals for the use of reduced doses of vaccination for adults.

Open document (PDF - 443 Kb)


https://www.dgs.pt/em-destaque/info...nfecao-humana-por-virus-monkeypox--n-010.aspx
 
Translation Google

Weekly information on Human Infection by Monkeypox Virus – Nº 011

i035847.jpg
​


Information on the number of cases in Portugal until September 14, 2022

On May 3, the presence of the Monkeypox virus (VMPX) was detected in Portugal, with laboratory confirmation of five cases of human infection by VMPX. Since then, until September 14, 2022, 908 confirmed cases have been identified.

As of September 14, 2022, 839 cases were reported on SINAVEmed (Figure 1). Of the 839 cases, most belong to the age group between 30 and 39 years (370; 44%). Most cases are male (831; 99%), with 8 cases (1%) reported in females.

Actions at national level

On July 16, vaccination of the first contacts close to cases began, according to the eligibility criteria of Norm 006/2022 of 07/12/2022. As of September 11, 437 contacts had been vaccinated. Eligible contacts in the different regions continue to be identified and targeted for vaccination.

The DGS published on September 15, 2022 the update of Guidance nº 004/2022 of May 31 on “Approach to cases of human infection by Monkeypox virus (VMPX)”, reinforcing the need to notify, investigate and test cases of VMPX infection. The update of Norm nº 006/2022 of July 12 will also be published, which will cover preventive vaccination for adults.

The DGS keeps track of the epidemiological situation, both nationally and internationally, sharing, analyzing and adapting scientific evidence and good practices in the implementation of public health measures aimed at reducing transmission chains.

Open document (PDF - 390 Kb)


https://www.dgs.pt/em-destaque/info...nfecao-humana-por-virus-monkeypox--n-011.aspx
 
Translation Google

Weekly information on Human Infection by Monkeypox Virus – Nº 012

i035864.jpg
​


Information on the number of cases in Portugal until September 21, 2022

On May 3, the presence of the Monkeypox virus (VMPX) was detected in Portugal, with laboratory confirmation of five cases of human infection by VMPX. Since then, until September 21, 2022, 917 confirmed cases have been identified.

As of September 21, 2022, 845 cases were reported on SINAVEmed (Figure 1). Of the 845 cases, most belong to the age group between 30 and 39 years (372; 44%). Most cases are male (837; 99%), with 8 cases (1%) reported in females.

Actions at national level

In addition to post-exposure vaccination, which started on July 16, 2022, in Portugal, the DGS updated on September 20, 2022 the Regulation 006/2022 of July 12, covering the administration of vaccines intradermally at reduced doses and preventive vaccination, covering groups at increased risk of human infection by VMPX.

The Monkeypox FAQ on the DGS website has been updated with information on the two types of vaccination. Preventive vaccination will be operationalized in the different regions of the country according to the technical and organizational aspects implemented, aiming at the adequate management of the availability, place of administration and use of vaccines.

As of September 18, 479 people had been vaccinated in the context of post-exposure vaccination, and eligible individuals in the different regions continue to be identified and targeted for vaccination.

The DGS keeps monitoring the epidemiological situation, both nationally and internationally, sharing, analyzing and adapting scientific evidence and good practices in the implementation of public health measures aimed at reducing transmission chains and controlling the outbreak.

Open document (PDF - 341 Kb)

https://www.dgs.pt/em-destaque/informacao-semanal-sobre-infecao-humana-por-virus-monkeypox--n-012.aspx
 
Translation Google


Highlights History

Weekly information on Human Infection by Monkeypox Virus – Nº 013
i035878.jpg
​



Information on the number of cases in Portugal until September 29, 2022

On May 3, the presence of the Monkeypox virus (VMPX) was detected in Portugal, with laboratory confirmation of five cases of human infection by VMPX. From then until September 28, 2022, 926 laboratory-confirmed cases were identified.

As of September 28, 2022, 851 cases were reported on SINAVEmed (Figure 1). Of the 851 cases, most belong to the age group between 30 and 39 years (375; 44%). Most cases are male (843; 99.1%), with 8 cases (0.9%) reported in females.

Actions at national level

From 16 July to 25 September, 500 contacts were vaccinated in the context of post-exposure vaccination.

In addition to post-exposure vaccination, preventive vaccination for groups at increased risk of human infection by VMPX started on September 26 in the LVT region and Central region, based on Standard 006/2022 updated on September 20. The remaining health regions are organizing and implementing the administration of vaccines in this context.

Frequently Asked Questions are available on the DGS website , with information on the two types of vaccination.

The DGS keeps monitoring the epidemiological situation, both nationally and internationally, sharing, analyzing and adapting scientific evidence and good practices in the implementation of public health measures aimed at reducing transmission chains and controlling the outbreak.

https://www.dgs.pt/em-destaque/infor...ox--n-013.aspx
 
Weekly information on Human Infection by Monkeypox Virus – Nº 014

i035893.jpg
​


Information on the number of cases in Portugal on October 6, 2022

On May 3, the presence of the Monkeypox virus (VMPX) was detected in Portugal, with laboratory confirmation of five cases of human infection by VMPX. From then until October 5, 2022, 930 laboratory-confirmed cases were identified, only 3 more compared to the previous week.

As of October 5, 2022, 855 cases had been reported on SINAVEmed, most of them in the age group between 30 and 39 years (375; 44%). Most cases are male (847; 99.1%), with 8 cases (0.9%) reported in females.

Actions at national level

From July 16 to October 2, 522 contacts were vaccinated in the context of post-exposure vaccination.

In addition to post-exposure vaccination, preventive vaccination for groups at increased risk of human infection by VMPX started on 26 September, based on Standard 006/2022 updated on 20 September. As of October 2, 88 people have been vaccinated in this context. The Regions of Lisbon and Vale do Tejo, Centre, North and Algarve are vaccinating in places identified by each ARS and the remaining regions are organizing the administration of vaccines in the preventive context.

Frequently asked questions are available on the DGS website, with information on the two types of vaccination, as well as an indication of preventive vaccination sites.

The DGS keeps monitoring the epidemiological situation, both nationally and internationally, sharing, analyzing and adapting scientific evidence and good practices in the implementation of public health measures aimed at reducing transmission chains and controlling the outbreak.

Open document (PDF - 476 Kb)


https://www.dgs.pt/em-destaque/info...infecao-humana-por-virus-monkeypox-n-014.aspx
 
Translation Google

Weekly Information on Human Infection by Monkeypox Virus – Nº 018
i036084.png
​



Information on the number of cases in Portugal on November 11, 2022


From May 3 to November 11, 2022, 948 laboratory-confirmed cases have been identified.

Since October 27, four (4) new confirmed cases have been reported in Portugal, revealing that the virus is still circulating among the most affected population.

From the beginning of vaccine availability (July 16th) until November 9th, 1190 people have already been vaccinated against VMPX infection in the context of the current outbreak, 614 of which in the context of preventive vaccination.

In Portugal, it is intended to reinforce vaccination aimed at reducing transmission chains and controlling the outbreak, which is why the efforts of clinicians who follow the groups at greater risk of exposure and infection are requested to complete the complete declaration of eligibility with vignette of the prescribing clinician or care provider service.

Frequently Asked Questions are available on the DGS website with information on the two types of vaccination and vaccination sites.

Different publicity materials on vaccination are also available, the printed version of which can be requested from the DGS via email comunicacao@dgs.min-saude.pt

Open document ( PDF - 494 Kb )


https://www.dgs.pt/em-destaque/infor...pox-n-018.aspx
 
Source: https://www.jn.pt/nacional/portugal-regista-a-primeira-morte-por-variola-dos-macacos-16515731.html

Portugal registers first death from monkeypox
Marisa Silva
Today at 12:56

Portugal recorded the first death due to monkeypox infection (mpox). He is a 23-year-old man who had been diagnosed in September last year. The victim was "HIV positive, non-adherent to antiretroviral therapy and with advanced immunosuppression", presenting "a rare condition of progressive and disseminated disease". Across the country, there are 953 confirmed cases of infection.

"In April 2023, a fatal case was confirmed in a 23-year-old male, HIV-positive, non-adherent to antiretroviral therapy and with advanced immunosuppression, who presented a rare condition of progressive and disseminated disease, diagnosed with Mpox in September 2022 and who died in January 2023", reads the most recent monthly report by the Directorate-General for Health (DGS), dated May 30.

The first cases of infection in Portugal appeared a year ago. It is recalled that, on May 3, 2022, the National Institute of Health Doctor Ricardo Jorge (INSA) confirmed the existence of five infected people. Since then and until May 28 of this year, 953 cases have been registered. All regions of mainland Portugal and the Autonomous Region of Madeira have reported cases. Most infections (77%) were registered in Lisbon and the Tagus Valley.​
 
Source: https://www.cmjornal.pt/sociedade/d...-casos-em-portugal?ref=Coronavírus_CMAoMinuto

49 cases of monkeypox detected since 1 June. Portugal exceeds the thousand cases
"Of the confirmed cases, 29 (74%) are men who had sex with men", says the health authority.
Lusa July 31, 2023 at 11:03 am

Forty-nine cases of Mpox were detected in Portugal, between June 1 and July 28, resulting from a new outbreak, according to data released by the Directorate-General for Health.

"This new outbreak is characterized by a different strain from the 2022 outbreak, reflecting the reintroduction of the virus in the highest risk group in Portugal and potentiated transmission chains in the context of events and summer festivals", adds the Directorate-General for Health (DGS) in a statement published on the website.

According to the DGS, all cases are men, mostly residents of the Lisbon and Tagus Valley Region (38), aged between 22 and 55 years (median 34 years).

"Of the confirmed cases, 29 (74%) are men who had sex with men", says the health authority.

Considering the 21 days prior to the onset of symptoms, 17 (44%) cases refer to frequenting saunas, 33 (85%) had sexual contact with multiple partners and 18 (46%) participated in group and/or anonymous sex activities, some in the context of summer festivals; no case refers to trips abroad".

Since the beginning of the Mpox outbreak in May 2022 and until July 28, 2023, 1002 laboratory-confirmed cases have been reported in Portugal, including one death, and since March 27, no new cases have been reported in Portugal.

According to DGS data, between July 16, 2022 and July 28, 2023, 4,823 people were vaccinated, most of which in the Lisbon and Tagus Valley region. Of the 8,009 inoculations, 7,054 occurred in a pre-exposure context.

In view of the resurgence of new cases in Portugal, the DGS reinforces the need to isolate cases and interrupt transmission chains between exposed individuals.
 
Source: https://www.dn.pt/sociedade/mpox-quase-100-casos-detetados-em-portugal-desde-junho-16950372.html

Mpox. Almost 100 cases detected in Portugal since June
According to the DGS, almost all cases are men (one female case), aged between 20 and 55 years, residing mainly in the regions of Lisbon and Vale do Tejo (89%) and the North (11% ).
DN/Lusa
01 September 2023 — 13:25

Almost 100 cases of Mpox have been detected in Portugal since June, resulting from the second outbreak of this contagious disease that remains active, with an average of five new cases reported per week, according to the Directorate-General for Health (DGS).

"In June 2023, a new outbreak was identified, after about three months without reported cases", says the DGS, specifying that, between June 1 and August 30 of this year, 97 laboratory confirmed cases were identified, 94 of which notified in the National Epidemiological Surveillance System, with a clinical profile similar to the previous outbreak.

According to the DGS, almost all cases are men (one female case), aged between 20 and 55 years (median 33), residing mostly in the regions of Lisbon and Vale do Tejo (89%) and the North (11%),

Of the confirmed cases, 74 (80%) are men who had sex with men, says the health authority, noting that "in terms of the clinical picture, rash [skin rash] was observed in 78 (83%) of the cases with available information ".

Of the cases with available information, 36 (38%) have HIV infection.

"Considering the 21 days prior to the onset of symptoms, 32 (34%) cases refer to frequenting saunas, 68 (72%) had sexual contacts with multiple partners and 31 (33%) participated in group and/or anonymous sex activities ; 5 (5%) cases refer to trips abroad", indicates the health authority.

In total, between May 3, 2022 and August 30, 2023, 1,050 cases of Mpox were identified in Portugal, including one death.

On 22 August, the WHO continued to consider that "the global risk is moderate, which is also the case in the European Region", with Portugal leading in the European region as the most affected countries, followed by the United Kingdom (19), Spain (10), France (4), Germany (3), the Netherlands (3), and Belgium, Luxembourg and Switzerland (2).

From the beginning of the availability of vaccines (on July 16, 2022) until August 30, 2023, 5,763 people were vaccinated, most of them in the Lisbon and Tagus Valley region. Of the 9,377 inoculations, 8,386 occurred in a pre-exposure context.

DGS reinforces the need for health professionals and civil society to move their efforts towards the early detection of new cases, the isolation of patients during the contagious period and vaccination with two doses within a 28-day interval of eligible groups, including by self-proposal.

The public health departments of the country's different health regions have "made efforts to expand the number of places available", with the list of vaccination sites available on the DGS website.

Worldwide, between January 1, 2022 and August 29, 2023, 89,596 confirmed cases and 663 probable cases of Mpox were reported to the World Health Organization (WHO), in 114 countries, including 157 deaths.

The number of new cases reported weekly worldwide increased by 40.8% in the week of 21 to 27 August compared to the previous week, with the majority of new cases in the last four weeks being reported in the Western Pacific Region (59.4 %) and in the Region of the Americas (23.5%).​
 
You must log in or register to reply here.
Back
Top